Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data.

Ali M, Fulton R, Quinn T, Brady M; VISTA Collaboration.

Stroke. 2013 Nov;44(11):3161-5. doi: 10.1161/STROKEAHA.113.001126. Epub 2013 Sep 19.

2.

Quality of life in stroke survivors after local intra-arterial thrombolysis.

Fischer U, Anca D, Arnold M, Nedeltchev K, Kappeler L, Ballinari P, Schroth G, Mattle HP.

Cerebrovasc Dis. 2008;25(5):438-44. doi: 10.1159/000126917. Epub 2008 Apr 16.

PMID:
18417961
3.

Patient outcomes in historical comparators compared with randomised-controlled trials.

Ali M, Jüttler E, Lees KR, Hacke W, Diedler J; VISTA and DESTINY Investigators.

Int J Stroke. 2010 Feb;5(1):10-5. doi: 10.1111/j.1747-4949.2009.00393.x.

PMID:
20088987
4.

Comparing clinician- and patient-reported outcome measures after hemicraniectomy for ischemic stroke.

Kelly ML, Rosenbaum BP, Kshettry VR, Weil RJ.

Clin Neurol Neurosurg. 2014 Nov;126:24-9. doi: 10.1016/j.clineuro.2014.08.007. Epub 2014 Aug 15.

PMID:
25194307
5.

Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.

Hallevi H, Albright KC, Martin-Schild SB, Barreto AD, Morales MM, Bornstein N, Ifejika NL, Shuaib A, Grotta JC, Savitz SI; VISTA investigators.

Cerebrovasc Dis. 2009;28(4):341-8. doi: 10.1159/000229552. Epub 2009 Jul 24.

PMID:
19628935
6.

Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).

Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U.

Stroke. 2007 Jun;38(6):1843-9. Epub 2007 Apr 26.

7.

Derivation and Validation of a Modified Short Form of the Stroke Impact Scale.

MacIsaac R, Ali M, Peters M, English C, Rodgers H, Jenkinson C, Lees KR, Quinn TJ; VISTA Collaboration.

J Am Heart Assoc. 2016 May 20;5(5). pii: e003108. doi: 10.1161/JAHA.115.003108.

8.

Association between disability measures and healthcare costs after initial treatment for acute stroke.

Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, Diener HC, Lees KR; GAIN and VISTA Investigators.

Stroke. 2007 Jun;38(6):1893-8. Epub 2007 Apr 19.

9.

Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories.

Rangaraju S, Haussen D, Nogueira RG, Nahab F, Frankel M.

Interv Neurol. 2017 Mar;6(1-2):36-41. doi: 10.1159/000452634. Epub 2016 Nov 16.

10.

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain.

Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MÁ, Torres C, Yebenes M, Quintana M, Alvarez-Sabín J; CONOCES Investigators Group.

Health Qual Life Outcomes. 2015 Mar 17;13:36. doi: 10.1186/s12955-015-0230-8.

11.

Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials.

Young FB, Weir CJ, Lees KR; GAIN International Trial Steering Committee and Investigators.

Stroke. 2005 Oct;36(10):2187-92. Epub 2005 Sep 22.

12.

Functional recovery at 3 months in stroke patients not receiving thrombolytic therapy: the comparison between patients arriving earlier and later than 4.5 hours.

Duangjit S, Muangpaisan W, Chotinaiwattarakul W, Dharmasaroja P.

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):91-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.003. Epub 2012 Nov 28.

PMID:
23200190
13.

Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial.

Sprigg N, Selby J, Fox L, Berge E, Whynes D, Bath PM; Efficacy of Nitric Oxide in Stroke Investigators.

Stroke. 2013 Dec;44(12):3458-62. doi: 10.1161/STROKEAHA.113.002201. Epub 2013 Oct 22.

14.

Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials.

Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ.

Stroke. 2005 Sep;36(9):1984-7. Epub 2005 Aug 4.

15.

Quality of life after intra-arterial therapy for acute ischemic stroke.

Cortez MM, Wilder MJ, McFadden M, Majersik JJ.

J Stroke Cerebrovasc Dis. 2014 Aug;23(7):1890-6. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.012. Epub 2014 May 9.

16.

Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.

Hacke W, Bluhmki E, Steiner T, Tatlisumak T, Mahagne MH, Sacchetti ML, Meier D.

Stroke. 1998 Oct;29(10):2073-5.

17.

Validity of EQ-5D-5L in stroke.

Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, Pickard AS.

Qual Life Res. 2015 Apr;24(4):845-50. doi: 10.1007/s11136-014-0834-1. Epub 2014 Oct 28.

18.

Clinical interpretation and use of stroke scales.

Kasner SE.

Lancet Neurol. 2006 Jul;5(7):603-12. Review.

PMID:
16781990
19.

Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.

Lubelski D, Alvin MD, Nesterenko S, Sundar SJ, Thompson NR, Benzel EC, Mroz TE.

J Neurosurg Spine. 2016 Mar;24(3):483-9. doi: 10.3171/2015.6.SPINE159. Epub 2015 Nov 27.

PMID:
26613280
20.

Intracluster correlation coefficients and reliability of randomized multicenter stroke trials within VISTA.

Frank B, Fulton RL, Goldie FC, Hacke W, Weimar C, Lees KR; VISTA Collaborators.

Int J Stroke. 2014 Jul;9(5):602-6. doi: 10.1111/ijs.12123. Epub 2013 Sep 5.

PMID:
24015969

Supplemental Content

Support Center